Insulin price caps pass Congress by end of 2026

Trump’s proposal to cap insulin costs at $35 per month gains bipartisan traction. The measure faces opposition from pharma but aligns with growing public demand. Passage would mark a rare policy win for Trump in a divided Congress.

Implied probability (Yes)

68%